85 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
not relied upon any Underwriter or legal counsel for any Underwriter for any legal, tax or accounting advice in connection with the offering and sale … and timely filed all federal, state, foreign and other tax returns or other statements that are or were required to be filed by it, if any, and has paid
424B5
oo8ptcr7
13 Mar 24
Prospectus supplement for primary offering
4:04pm
424B5
0q4y7ps28zd6h
11 Mar 24
Prospectus supplement for primary offering
4:06pm
8-K
EX-10.1
sqbg lb3yn0vlja5
20 Feb 24
Departure of Directors or Certain Officers
4:44pm
424B4
86rmbj 4fd0
8 Jan 24
Prospectus supplement with pricing info
4:11pm
8-K
EX-99.1
ti1h2gbkstyjfg
8 Aug 23
Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
kml1vr9rwnjixy
4 May 23
Cognition Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:06pm
8-K
EX-10.1
36vsok83hoxg
1 May 23
Departure of Directors or Certain Officers
7:30am
8-K
EX-10.1
n0wcd76u
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
S-3
EX-4.4
jfyldk ak
23 Dec 22
Shelf registration
4:16pm
S-3
wynop72jertvm0e
23 Dec 22
Shelf registration
4:16pm